Board of Directors

Our Board

MaRS Innovation’s Board of Directors draws from expertise within our members and from independent directors with relevant industry experience. The board provides crucial governance to MaRS Innovation as a whole and to several key business areas. The Investment Committee, for example, provides oversight to portfolio investment decisions.

The Networks of Centres of Excellence recognizes MI’s board structure for its high degree of accountability and for the rigour of its governance policies.

Photo of Rafi Hofstein Rafi Hofstein President & CEO

Dr. Raphael (Rafi) Hofstein joined MaRS Innovation as President and CEO in June 2009. He is currently member of the board of directors of Life Science Ontario and of Clinical Trials Ontario, as well as a member of the Organizing Committee of the Public Policy Forum on Venture Capital and Innovation (part of the Quebec City Conference) and part of the Ontario Health Innovation Council (OHIC).…

Photo of Dr. Michael ApkonDr. Michael Apkon MBA, MD, PhD, President and CEO, The Hospital for Sick Children (SickKids)

Dr. Michael Apkon, MBA, MD, PhD, was appointed President and CEO for The Hospital for Sick Children (SickKids) on January 1, 2014. Dr. Apkon has a BSc degree in Biomedical Engineering from Northwestern University as well as MD and PhD degrees from Washington University School of Medicine in St. Louis and an MBA from the Yale School of Management.…

Photo of Jessica Chutter Jessica Chutter Managing Director, Chairman of Biotechnology Investment Banking, Morgan Stanley

Jessica is the managing director and chairman of Biotechnology Investment Banking at Morgan Stanley. During Jessica’s 30-year career of building Morgan Stanley’s biotechnology franchise, she has been responsible for $30 billion of capital raising and $65B of strategic transactions. In 2017, transactions include leading financings for Axovant, Biohaven, Editas, Galapagos, RegenxBio and Syndax, aggregating $1Bn in proceeds. …

Photo of Dr. Vivek GoelDr. Vivek Goel PhD, Vice President, Research and Innovation, University of Toronto

Professor Vivek Goel was appointed Vice President, Research and Innovation of the University of Toronto in December, 2014. Professor Goel is a distinguished scholar with an extensive background in teaching, research and university administration. He obtained his medical degree from McGill University and completed post-graduate medical training in Community Medicine at the University of Toronto. Dr.…

Photo of Angus J. Grant PhD Angus J. Grant PhDCorporate Vice President, Business Development, Celgene Corporation

Angus Grant joined Celgene as Vice President North American Regulatory Affairs in 2006, in the Summit NJ Headquarters.  In 2008, Angus moved to London as Head of Europe RA for 3 years. Angus returned to the Summit NJ Headquarters as VP, Business Development and Global Alliances, in 2011, where he has since completed multiple innovative deals and has in tandem built the Alliance Management function, which now manages over 50 collaborations and investments with pharmaceutical and biotech partners.…

Photo of Laurie Harrison Laurie Harrison Vice President, CFO

Ms. Harrison has 30 years of experience in Ontario healthcare organizations providing strategic and operational leadership in Finance, Business Development, Treasury, Strategic Planning, Human Resources, and Operations Ms. Harrison has a BSc degree in Business Administration from the University of Tennessee as well as an MBA from Northwestern (Kellogg) and York Universities.  She holds the Certified Public Accountant designation. …

Photo of Douglas Heintzman Douglas Heintzman Consultant, Technology Strategist

Douglas Heintzman is currently the practice lead for Blockchain technology at the Burnie Group, a management and technology consultancy firm. He is focused on driving digital health technologies, specifically automation and Blockchain into healthcare with the intent of delivering better patient outcomes more cost effectively. He has been in the IT industry for 28 years. He has been an entrepreneur in the Mobile Context Adaptive space and  was at IBM for 25 years, mostly as a headquarters world wide strategy executive.  …

Photo of Timothy H. Penner Timothy H. Penner Chair, Board of Directors. Retired President and CEO, Proctor & Gamble

Tim Penner recently retired from his position as president and CEO of Proctor & Gamble Inc. after 33 years of service. From 1993 to 1996, he was vice-president of Proctor & Gamble‘s health and beauty care business in the United Kingdom. From 1996 to 1999, Penner was vice-president of Proctor & Gamble’s North American tissue/towel business, which was based in the United States.…

Photo of Mario Piccinin Mario Piccinin MBA, CPA, CA – Partner, Ernst & Young LLP

Mario is an Audit Partner and the Greater Toronto Area Life Science Leader at EY with 26 years of experience providing audit and business advisory services to private and public companies in a variety of industries. His practice is focused on Life Science companies including Healthcare, Diagnostic, Med Tech, Pharma and Biotechnology companies. Mario has had extensive hands on experience working with companies in all aspects of their life cycles, from start-up to mature organizations, helping them achieve their goals.…

Photo of Mike Rhodin Mike Rhodin (Retired) Senior Vice President of IBM; Founder of the Watson Group

Mike Rhodin recently retired from IBM after 33 years,  and 7 years as a corporate officer.  Most recently he was responsible for founding the IBM Watson business units.  Prior to that,  Mike founded IBM’s solution units around their Smarter Planet initiatives including Smarter Cities,  Smarter Commerce and Smarter Analytics.  During the last financial crisis,  Mike was based in Zurich, Switzerland and responsible for most of IBM’s European operations.…

Photo of Dr. Andy J. SmithDr. Andy J. Smith President & CEO, Sunnybrook Health Sciences Centre
Photo of Salim Teja Salim Teja President, Ventures – MaRS Discovery District

Salim Teja is President, Venture Services, for MaRS Discovery District, where he leads the overall strategic direction of MaRS’ three venture services areas: Health, ICT and Cleantech. He is an experienced entrepreneur and active early-stage technology investor, with deep industry expertise in software and digital media. Salim joined MaRS in May 2013, providing strategic direction and leadership for MaRS’ ICT venture services group, leading corporate and venture capital engagement, and overseeing MaRS’ expanding international collaborations in the ICT sector.…

Photo of Dr. Bradly G. WoutersDr. Bradly G. Wouters Executive Vice President, Science & Research

Dr. Bradly Wouters is an internationally recognized leader and cancer researcher. He became Executive Vice President of Science and Research at UHN in 2016 and prior to that served as the Interim Director of Research at the Princess Margaret Cancer Centre since 2014. He joined UHN in 2008 as Senior Scientist and Director of the Princess Margaret Hypoxia Program, and has held faculty appointments at the University of Toronto in the Department of Medical Biophysics and the Department of Radiation Oncology since that time.…

Photo of Dr. Catherine ZahnDr. Catherine Zahn President & CEO

Dr. Zahn was appointed President and CEO of the Centre for Addiction and Mental Health (CAMH) in 2009.  CAMH is Canada’s leading mental health hospital and the country’s largest academic health science centre focused on mental illness. She received her MD (honours) from the Faculty of Medicine at the University of Toronto (U of T), where she completed her residency training in neurology. …